CXCR4 and cancer: Thus, T22-DITOX-H6’s ability to eliminate CXCR4+ cancer cells presenting a more invasive and metastatic phenotype blocks HNSCC’s invasiveness and its metastatic dissemination to the cervical lymph nodes, lungs, and liver, in the absence of histopathological alterations.